HETEROCYCLIC SULFONES AS ROR GAMMA MODULATORS

There are described RORγ modulators of the formula (I), or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates, or prodrugs thereof, wherein all substituents are defined herein. Also provided are pharmaceutical compositions comprising the same. Such compounds and compositions are u...

Full description

Saved in:
Bibliographic Details
Main Authors Dhar, T.G. Murali, Xiao, Hai-Yun, Cornelius, Lyndon A.M, Li, Jianqing, Cherney, Robert J, Qin, Lan-ying, LIU, Qingjie
Format Patent
LanguageEnglish
Published 03.10.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:There are described RORγ modulators of the formula (I), or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates, or prodrugs thereof, wherein all substituents are defined herein. Also provided are pharmaceutical compositions comprising the same. Such compounds and compositions are useful in methods for modulating RORγ Gamma activity in a cell and methods for treating a subject suffering from a disease or disorder in which the subject would therapeutically benefit from modulation of RORγ Gamma activity, for example, autoimmune and/or inflammatory disorders.
Bibliography:Application Number: US201716341474